{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:11:38Z","timestamp":1787062298075,"version":"build-2736575974"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160818"],"award-info":[{"award-number":["82160818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22JR5RA622"],"award-info":[{"award-number":["22JR5RA622"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11596-025-00079-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:32:58Z","timestamp":1751855578000},"page":"841-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Key Transcription Factors: Avenue for Treating Alcoholic Liver Disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Min","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-nan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"5","key":"79_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.36290\/vnl.2020.091","volume":"66","author":"J Ehrmann","year":"2020","unstructured":"Ehrmann J, Aiglov\u00e1 K, Urban O, et al. Alcohol-related liver diseases (ALD). Vnitr Lek. 2020;66(5):39\u201351.","journal-title":"Vnitr Lek."},{"issue":"14","key":"79_CR2","first-page":"V11200893","volume":"183","author":"G Askgaard","year":"2021","unstructured":"Askgaard G, Kraglund F, Kann AE, et al. Epidemiology for alcohol-related liver disease. Ugeskr Laeger. 2021;183(14):V11200893.","journal-title":"Ugeskr Laeger."},{"issue":"5","key":"79_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jhepr.2019.07.009","volume":"1","author":"M Ventura-Cots","year":"2019","unstructured":"Ventura-Cots M, Ballester-Ferr\u00e9 MP, Ravi S, et al. Public health policies and alcohol-related liver disease. JHEP Rep. 2019;1(5):403\u2013413.","journal-title":"JHEP Rep."},{"issue":"10","key":"79_CR4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.3390\/biomedicines10102530","volume":"10","author":"Y Ha","year":"2022","unstructured":"Ha Y, Jeong I, Kim TH. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines. 2022;10(10):2530.","journal-title":"Biomedicines."},{"issue":"6","key":"79_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/HEP.0000000000000899","volume":"80","author":"F \u00c5berg","year":"2024","unstructured":"\u00c5berg F, Jiang ZG, Cortez-Pinto H, et al. Alcohol-associated liver disease-Global epidemiology. Hepatology. 2024;80(6):1307\u20131322.","journal-title":"Hepatology."},{"issue":"3","key":"79_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176345","volume":"134","author":"B Mackowiak","year":"2024","unstructured":"Mackowiak B, Fu Y, Maccioni L, et al. Alcohol-associated liver disease. J Clin Invest. 2024;134(3):e176345.","journal-title":"J Clin Invest."},{"issue":"1","key":"79_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MED.0000000000000782","volume":"30","author":"J Gujral","year":"2023","unstructured":"Gujral J, Sethuram S. An update on the diagnosis and treatment of adrenoleukodystrophy. Curr Opin Endocrinol Diabetes Obes. 2023;30(1):44\u201351.","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"10","key":"79_CR8","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms22105170","volume":"22","author":"SY Liu","year":"2021","unstructured":"Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci. 2021;22(10):5170.","journal-title":"Int J Mol Sci."},{"key":"79_CR9","doi-asserted-by":"publisher","first-page":"1432480","DOI":"10.3389\/fphar.2024.1432480","volume":"15","author":"X Hong","year":"2024","unstructured":"Hong X, Huang S, Jiang H, et al. Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models. Front Pharmacol. 2024;15:1432480.","journal-title":"Front Pharmacol."},{"key":"79_CR10","doi-asserted-by":"publisher","first-page":"119328","DOI":"10.1016\/j.lfs.2021.119328","volume":"274","author":"A Namachivayam","year":"2021","unstructured":"Namachivayam A, Valsala Gopalakrishnan A. A review on molecular mechanism of alcoholic liver disease. Life Sci. 2021;274:119328.","journal-title":"Life Sci."},{"issue":"1","key":"79_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cld.2018.09.006","volume":"23","author":"T Kourkoumpetis","year":"2019","unstructured":"Kourkoumpetis T, Sood G. Pathogenesis of Alcoholic Liver Disease: An Update. Clin Liver Dis. 2019;23(1):71\u201380.","journal-title":"Clin Liver Dis."},{"issue":"4","key":"79_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, et al. The Human Transcription Factors. Cell. 2018;172(4):650\u2013665.","journal-title":"Cell."},{"issue":"4","key":"79_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrg2538","volume":"10","author":"JM Vaquerizas","year":"2009","unstructured":"Vaquerizas JM, Kummerfeld SK, Teichmann SA, et al. A census of human transcription factors: function, expression and evolution. Nat Rev Genet. 2009;10(4):252\u2013263.","journal-title":"Nat Rev Genet."},{"issue":"1","key":"79_CR14","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1038\/s41467-023-40943-1","volume":"14","author":"S Hendrix","year":"2023","unstructured":"Hendrix S, Kingma J, Ottenhoff R, et al. Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans. Nat Commun. 2023;14(1):5181.","journal-title":"Nat Commun."},{"issue":"20","key":"79_CR15","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1042\/BCJ20210071","volume":"478","author":"P Ferr\u00e9","year":"2021","unstructured":"Ferr\u00e9 P, Phan F, Foufelle F. SREBP-1c and lipogenesis in the liver: an update1. Biochem J. 2021;478(20):3723\u20133739.","journal-title":"Biochem J."},{"issue":"4","key":"79_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/jmf.2021.K.0098","volume":"25","author":"M Lee","year":"2022","unstructured":"Lee M, Nam SH, Yoon HG, et al. Fermented Curcuma longa L. Prevents Alcoholic Fatty Liver Disease in Mice by Regulating CYP2E1, SREBP-1c, and PPAR-\u03b1. J Med Food. 2022;25(4):456\u2013463.","journal-title":"J Med Food."},{"issue":"12","key":"79_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.158521","volume":"1864","author":"DK Kim","year":"2019","unstructured":"Kim DK, Kim YH, Lee JH, et al. Estrogen-related receptor \u03b3 controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(12):158521.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"issue":"2","key":"79_CR18","first-page":"88","volume":"4","author":"M You","year":"2015","unstructured":"You M, Jogasuria A, Taylor C, et al. Sirtuin 1 signaling and alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2015;4(2):88\u2013100.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"44","key":"79_CR19","doi-asserted-by":"publisher","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","volume":"285","author":"B Ponugoti","year":"2010","unstructured":"Ponugoti B, Kim DH, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem. 2010;285(44):33959\u201333970.","journal-title":"J Biol Chem."},{"issue":"11","key":"79_CR20","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288\u20131295","journal-title":"Nat Med."},{"issue":"11","key":"79_CR21","first-page":"1613","volume":"11","author":"N Attal","year":"2022","unstructured":"Attal N, Marrero E, Thompson KJ, et al. Role of AMPK-SREBP Signaling in Regulating Fatty Acid Binding-4 (FABP4) Expression following Ethanol Metabolism. Biology (Basel). 2022;11(11):1613.","journal-title":"Biology (Basel)."},{"issue":"6","key":"79_CR22","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","volume":"127","author":"M You","year":"2004","unstructured":"You M, Matsumoto M, Pacold CM, et al. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004;127(6):1798\u20131808.","journal-title":"Gastroenterology."},{"issue":"5","key":"79_CR23","first-page":"614","volume":"232","author":"M Endo","year":"2007","unstructured":"Endo M, Masaki T, Seike M, et al. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood). 2007;232(5):614\u2013621.","journal-title":"Exp Biol Med (Maywood)."},{"issue":"6","key":"79_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1566524033479537","volume":"3","author":"S Yu","year":"2003","unstructured":"Yu S, Rao S, Reddy JK. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med. 2003;3(6):561\u2013572.","journal-title":"Curr Mol Med."},{"issue":"1","key":"79_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","volume":"40","author":"L Kong","year":"2021","unstructured":"Kong L, Chen J, Ji X, et al. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPAR\u03b1 to activate the NF-\u03baB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance. J Exp Clin Cancer Res. 2021;40(1):18.","journal-title":"J Exp Clin Cancer Res."},{"key":"79_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2021.08.005","volume":"174","author":"R Yue","year":"2021","unstructured":"Yue R, Chen GY, Xie G, et al. Activation of PPAR\u03b1-catalase pathway reverses alcoholic liver injury via upregulating NAD synthesis and accelerating alcohol clearance. Free Radic Biol Med. 2021;174:249\u2013263.","journal-title":"Free Radic Biol Med."},{"issue":"1","key":"79_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1124\/jpet.103.064717","volume":"310","author":"AA Nanji","year":"2004","unstructured":"Nanji AA, Dannenberg AJ, Jokelainen K, et al. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. J Pharmacol Exp Ther. 2004;310(1):417\u2013424.","journal-title":"J Pharmacol Exp Ther."},{"issue":"30","key":"79_CR28","doi-asserted-by":"publisher","first-page":"27997","DOI":"10.1074\/jbc.M302140200","volume":"278","author":"M Fischer","year":"2003","unstructured":"Fischer M, You M, Matsumoto M, et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem. 2003;278(30):27997\u201328004.","journal-title":"J Biol Chem."},{"issue":"1","key":"79_CR29","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00056.2004","volume":"287","author":"M You","year":"2004","unstructured":"You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004;287(1):G1\u2013G6.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"3","key":"79_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/hep.20821","volume":"42","author":"M You","year":"2005","unstructured":"You M, Considine RV, Leone TC, et al. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology. 2005;42(3):568\u2013577.","journal-title":"Hepatology."},{"issue":"3","key":"79_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/hep.22074","volume":"47","author":"Z Song","year":"2008","unstructured":"Song Z, Zhou Z, Deaciuc I, et al. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology. 2008;47(3):867\u2013879.","journal-title":"Hepatology"},{"issue":"5","key":"79_CR32","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","volume":"20","author":"RB Vega","year":"2000","unstructured":"Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000;20(5):1868\u20131876.","journal-title":"Mol Cell Biol."},{"issue":"4","key":"79_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","volume":"9","author":"A Purushotham","year":"2009","unstructured":"Purushotham A, Schug TT, Xu Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009;9(4):327\u2013338.","journal-title":"Cell Metab."},{"issue":"8","key":"79_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.bbapap.2009.11.021","volume":"1804","author":"DJ Lomb","year":"2010","unstructured":"Lomb DJ, Laurent G, Haigis MC. Sirtuins regulate key aspects of lipid metabolism. Biochim Biophys Acta. 2010;1804(8):1652\u20131657.","journal-title":"Biochim Biophys Acta."},{"issue":"11","key":"79_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1535370217707729","volume":"242","author":"Y Li","year":"2017","unstructured":"Li Y, Zhou J. Roles of silent information regulator 1-serine\/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease. Exp Biol Med (Maywood). 2017;242(11):1117\u20131125.","journal-title":"Exp Biol Med (Maywood)."},{"key":"79_CR36","doi-asserted-by":"publisher","first-page":"8167273","DOI":"10.1155\/2016\/8167273","volume":"2016","author":"VT Vachharajani","year":"2016","unstructured":"Vachharajani VT, Liu T, Wang X, et al. Sirtuins Link Inflammation and Metabolism. J Immunol Res. 2016;2016:8167273.","journal-title":"J Immunol Res."},{"issue":"16","key":"79_CR37","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.7150\/ijbs.49535","volume":"16","author":"R Ren","year":"2020","unstructured":"Ren R, Wang Z, Wu M, et al. Emerging Roles of SIRT1 in Alcoholic Liver Disease. Int J Biol Sci. 2020;16(16):3174\u20133183.","journal-title":"Int J Biol Sci."},{"issue":"4","key":"79_CR38","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/acs.molpharmaceut.2c00904","volume":"20","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen Z, Wang Y, et al. Noninvasive Positron Emission Tomography Imaging of SIRT1 in a Model of Early-Stage Alcoholic Liver Disease. Mol Pharm. 2023;20(4):1990\u20131995.","journal-title":"Mol Pharm."},{"issue":"4","key":"79_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0033-1358523","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, So JS, Park JG, et al. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis. 2013;33(4):301\u2013311.","journal-title":"Semin Liver Dis."},{"issue":"2","key":"79_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2310\/JIM.0b013e31827c2795","volume":"61","author":"S Liangpunsakul","year":"2013","unstructured":"Liangpunsakul S, Ross RA, Crabb DW. Activation of carbohydrate response element-binding protein by ethanol. J Investig Med. 2013;61(2):270\u2013277.","journal-title":"J Investig Med."},{"issue":"4","key":"79_CR41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/hep.27778","volume":"62","author":"S Marmier","year":"2015","unstructured":"Marmier S, Dentin R, Daujat-Chavanieu M, et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology. 2015;62(4):1086\u20131100.","journal-title":"Hepatology."},{"issue":"4","key":"79_CR42","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/hep.20400","volume":"40","author":"F Hong","year":"2004","unstructured":"Hong F, Radaeva S, Pan H, et al. Interleukin 6 alleviates hepatic steatosis and ischemia\/reperfusion injury in mice with fatty liver disease. Hepatology. 2004;40(4):933\u2013941.","journal-title":"Hepatology."},{"issue":"5","key":"79_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","volume":"35","author":"AM Miller","year":"2011","unstructured":"Miller AM, Horiguchi N, Jeong WI, et al. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011;35(5):787\u2013793.","journal-title":"Alcohol Clin Exp Res."},{"issue":"3","key":"79_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/biom6030029","volume":"6","author":"RA Ansari","year":"2016","unstructured":"Ansari RA, Husain K, Rizvi SAA. Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of Metabolism. Biomolecules. 2016;6(3):29.","journal-title":"Biomolecules."},{"issue":"10","key":"79_CR45","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00109-019-01808-7","volume":"97","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Hou S, Zhai J, et al. S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver. J Mol Med (Berl). 2019;97(10):1399\u20131412.","journal-title":"J Mol Med (Berl)."},{"issue":"7","key":"79_CR46","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","volume":"23","author":"MC Alessi","year":"2003","unstructured":"Alessi MC, Bastelica D, Mavri A, et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23(7):1262\u20131268.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"7","key":"79_CR47","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1053\/j.gastro.2006.03.020","volume":"130","author":"I Bergheim","year":"2006","unstructured":"Bergheim I, Guo L, Davis MA, et al. Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1. Gastroenterology. 2006;130(7):2099\u20132112.","journal-title":"Gastroenterology."},{"issue":"1","key":"79_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/ebm.2011.011255","volume":"237","author":"JI Beier","year":"2012","unstructured":"Beier JI, Arteel GE. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism. Exp Biol Med (Maywood). 2012;237(1):1\u20139.","journal-title":"Exp Biol Med (Maywood)."},{"issue":"10","key":"79_CR49","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cr.2014.120","volume":"24","author":"Y Chu","year":"2014","unstructured":"Chu Y, G\u00f3mez Rosso L, Huang P, et al. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity. Cell Res. 2014;24(10):1250\u20131265.","journal-title":"Cell Res."},{"issue":"2","key":"79_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/ars.2010.3780","volume":"15","author":"X Liang","year":"2011","unstructured":"Liang X, Hu M, Rogers CQ, et al. Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxid Redox Signal. 2011;15(2):425\u2013435.","journal-title":"Antioxid Redox Signal."},{"issue":"11","key":"79_CR51","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3748\/wjg.v16.i11.1304","volume":"16","author":"HJ Wang","year":"2010","unstructured":"Wang HJ, Zakhari S, Jung MK. Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gastroenterol. 2010;16(11):1304\u20131313.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"79_CR52","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/ijms24043735","volume":"24","author":"M Duki\u0107","year":"2023","unstructured":"Duki\u0107 M, Radonji\u0107 T, Jovanovi\u0107 I, et al. Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease. Int J Mol Sci. 2023;24(4):3735.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"79_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC. The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545\u2013558.","journal-title":"Nat Rev Immunol."},{"issue":"8","key":"79_CR54","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/153537020322800803","volume":"228","author":"LE Nagy","year":"2003","unstructured":"Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood). 2003;228(8):882\u2013890.","journal-title":"Exp Biol Med (Maywood)."},{"issue":"6","key":"79_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","volume":"50","author":"P Mandrekar","year":"2009","unstructured":"Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 2009;50(6):1258\u20131266.","journal-title":"J Hepatol."},{"key":"79_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0079-6603(08)60815-6","volume":"50","author":"A Gashler","year":"1995","unstructured":"Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol. 1995;50:191\u2013224.","journal-title":"Prog Nucleic Acid Res Mol Biol."},{"issue":"11 Suppl","key":"79_CR57","first-page":"146S","volume":"29","author":"MT Pritchard","year":"2005","unstructured":"Pritchard MT, Nagy LE. Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res. 2005;29(11 Suppl):146S-150S.","journal-title":"Alcohol Clin Exp Res."},{"issue":"1","key":"79_CR58","doi-asserted-by":"publisher","first-page":"G6","DOI":"10.1152\/ajpgi.00328.2001","volume":"282","author":"R Kishore","year":"2002","unstructured":"Kishore R, Hill JR, McMullen MR, et al. ERK1\/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol. 2002;282(1):G6\u2013G15.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"79_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115026","volume":"200","author":"M Al Hamrashdi","year":"2022","unstructured":"Al Hamrashdi M, Brady G. Regulation of IRF3 activation in human antiviral signaling pathways. Biochem Pharmacol. 2022;200:115026.","journal-title":"Biochem Pharmacol."},{"issue":"2","key":"79_CR60","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/hep.24059","volume":"53","author":"J Petrasek","year":"2011","unstructured":"Petrasek J, Dolganiuc A, Csak T, et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology. 2011;53(2):649\u2013660.","journal-title":"Hepatology."},{"issue":"2\u20133","key":"79_CR61","first-page":"129","volume":"1072","author":"P Angel","year":"1991","unstructured":"Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072(2\u20133):129\u2013157.","journal-title":"Biochim Biophys Acta."},{"issue":"4","key":"79_CR62","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00018-019-03297-w","volume":"77","author":"W Liu","year":"2020","unstructured":"Liu W, Li Y, Luo B. Current perspective on the regulation of FOXO4 and its role in disease progression. Cell Mol Life Sci. 2020;77(4):651\u2013663.","journal-title":"Cell Mol Life Sci."},{"key":"79_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107572","volume":"96","author":"L Sang","year":"2021","unstructured":"Sang L, Kang K, Sun Y, et al. FOXO4 ameliorates alcohol-induced chronic liver injury via inhibiting NF-\u03baB and modulating gut microbiota in C57BL\/6J mice. Int Immunopharmacol. 2021;96:107572.","journal-title":"Int Immunopharmacol."},{"issue":"11 Suppl","key":"79_CR64","first-page":"110S","volume":"29","author":"T Zima","year":"2005","unstructured":"Zima T, Kalousov\u00e1 M. Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol Clin Exp Res. 2005;29(11 Suppl):110S\u2013115S.","journal-title":"Alcohol Clin Exp Res."},{"issue":"5 Suppl ISBRA","key":"79_CR65","doi-asserted-by":"publisher","first-page":"237S","DOI":"10.1111\/j.1530-0277.2001.tb02402.x","volume":"25","author":"AY Sun","year":"2001","unstructured":"Sun AY, Ingelman-Sundberg M, Neve E, et al. Ethanol and oxidative stress. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):237S\u2013243S.","journal-title":"Alcohol Clin Exp Res."},{"issue":"3","key":"79_CR66","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jcmgh.2021.05.013","volume":"12","author":"H Dong","year":"2021","unstructured":"Dong H, Hao L, Zhang W, et al. Activation of AhR-NQO1 Signaling Pathway Protects Against Alcohol-Induced Liver Injury by Improving Redox Balance. Cell Mol Gastroenterol Hepatol. 2021;12(3):793\u2013811.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"1","key":"79_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jat.3880","volume":"40","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol. 2020;40(1):151\u2013168.","journal-title":"J Appl Toxicol."},{"issue":"17","key":"79_CR68","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221\u20133247.","journal-title":"Cell Mol Life Sci."},{"issue":"36","key":"79_CR69","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","volume":"20","author":"W Tang","year":"2014","unstructured":"Tang W, Jiang Y-F, Ponnusamy M, et al. Role of Nrf2 in chronic liver disease. World J Gastroenterol. 2014;20(36):13079\u201313087.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"79_CR70","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.26126","volume":"57","author":"H Jo","year":"2013","unstructured":"Jo H, Choe SS, Shin KC, et al. Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology. 2013;57(4):1366\u20131377.","journal-title":"Hepatology."},{"issue":"3","key":"79_CR71","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jb\/mvx074","volume":"163","author":"I Kudo","year":"2018","unstructured":"Kudo I, Hosaka M, Haga A, et al. The regulation mechanisms of AhR by molecular chaperone complex. J Biochem. 2018;163(3):223\u2013232.","journal-title":"J Biochem."},{"issue":"4","key":"79_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells9040837","volume":"9","author":"X Ma","year":"2020","unstructured":"Ma X, McKeen T, Zhang J, et al. Role and Mechanisms of Mitophagy in Liver Diseases. Cells. 2020;9(4):837.","journal-title":"Cells."},{"issue":"4","key":"79_CR73","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1128\/MCB.25.4.1354-1366.2005","volume":"25","author":"N Gleyzer","year":"2005","unstructured":"Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol. 2005;25(4):1354\u20131366.","journal-title":"Mol Cell Biol."},{"issue":"5","key":"79_CR74","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/hep.24279","volume":"53","author":"L Dara","year":"2011","unstructured":"Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology. 2011;53(5):1752\u20131763.","journal-title":"Hepatology."},{"issue":"3","key":"79_CR75","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology. 2018;155(3):629\u2013647.","journal-title":"Gastroenterology."},{"issue":"3","key":"79_CR76","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","volume":"3","author":"M Setshedi","year":"2010","unstructured":"Setshedi M, Wands JR, Monte SM de la. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev. 2010;3(3):178\u2013185.","journal-title":"Oxid Med Cell Longev."},{"issue":"1","key":"79_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/08830185.2010.522281","volume":"30","author":"M Kitamura","year":"2011","unstructured":"Kitamura M. Control of NF-\u03baB and inflammation by the unfolded protein response. Int Rev Immunol. 2011;30(1):4\u201315.","journal-title":"Int Rev Immunol."},{"issue":"4","key":"79_CR78","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54(4):795\u2013809.","journal-title":"J Hepatol."},{"issue":"7","key":"79_CR79","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1083\/jcb.201702058","volume":"216","author":"PM Quir\u00f3s","year":"2017","unstructured":"Quir\u00f3s PM, Prado MA, Zamboni N, et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216(7):2027\u20132045.","journal-title":"J Cell Biol."},{"key":"79_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/513787","volume":"2014","author":"C Ji","year":"2014","unstructured":"Ji C. New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. Int J Hepatol. 2014;2014:513787.","journal-title":"Int J Hepatol."},{"issue":"35","key":"79_CR81","doi-asserted-by":"publisher","first-page":"18536","DOI":"10.1074\/jbc.M116.726836","volume":"291","author":"K Li","year":"2016","unstructured":"Li K, Xiao Y, Yu J, et al. Liver-specific Gene Inactivation of the Transcription Factor ATF4 Alleviates Alcoholic Liver Steatosis in Mice. J Biol Chem. 2016;291(35):18536\u201318546.","journal-title":"J Biol Chem."},{"issue":"Suppl 3","key":"79_CR82","first-page":"S7","volume":"21","author":"N Kaplowitz","year":"2006","unstructured":"Kaplowitz N, Ji C. Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum. J Gastroenterol Hepatol. 2006;21 Suppl 3:S7\u2013S9.","journal-title":"J Gastroenterol Hepatol."},{"issue":"Pt 10","key":"79_CR83","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1242\/jcs.045625","volume":"122","author":"H Bommiasamy","year":"2009","unstructured":"Bommiasamy H, Back SH, Fagone P, et al. ATF6alpha induces XBP1-independent expansion of the endoplasmic reticulum. J Cell Sci. 2009;122(Pt 10):1626\u20131636.","journal-title":"J Cell Sci."},{"issue":"1","key":"79_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","volume":"3","author":"J Shen","year":"2002","unstructured":"Shen J, Chen X, Hendershot L, et al. ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals. Dev Cell. 2002;3(1):99\u2013111.","journal-title":"Dev Cell."},{"issue":"5","key":"79_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004335","volume":"10","author":"DL Howarth","year":"2014","unstructured":"Howarth DL, Lindtner C, Vacaru AM, et al. Activating transcription factor 6 is necessary and sufficient for alcoholic fatty liver disease in zebrafish. PLoS Genet. 2014;10(5):e1004335.","journal-title":"PLoS Genet."},{"key":"79_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105218","volume":"161","author":"SW Xia","year":"2020","unstructured":"Xia SW, Wang ZM, Sun SM, et al. Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacol Res. 2020;161:105218.","journal-title":"Pharmacol Res."},{"issue":"3","key":"79_CR87","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","volume":"124","author":"K Zhang","year":"2006","unstructured":"Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell. 2006;124(3):587\u2013599.","journal-title":"Cell."},{"issue":"1","key":"79_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3727\/105221610X12819686555051","volume":"15","author":"Y He","year":"2010","unstructured":"He Y, Sun S, Sha H, et al. Emerging roles for XBP1, a sUPeR transcription factor. Gene Expr. 2010;15(1):13\u201325.","journal-title":"Gene Expr."},{"issue":"2","key":"79_CR89","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1534-5807(03)00022-4","volume":"4","author":"H Yoshida","year":"2003","unstructured":"Yoshida H, Matsui T, Hosokawa N, et al. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell. 2003;4(2):265\u2013271.","journal-title":"Dev Cell."},{"issue":"33","key":"79_CR90","doi-asserted-by":"publisher","first-page":"17394","DOI":"10.1074\/jbc.M116.728949","volume":"291","author":"H Herrema","year":"2016","unstructured":"Herrema H, Zhou Y, Zhang D, et al. XBP1s Is an Anti-lipogenic Protein. J Biol Chem. 2016;291(33):17394\u201317404.","journal-title":"J Biol Chem."},{"issue":"5","key":"79_CR91","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1053\/j.gastro.2010.07.041","volume":"139","author":"WX Ding","year":"2010","unstructured":"Ding WX, Li M, Chen X, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology. 2010;139(5):1740\u20131752.","journal-title":"Gastroenterology."},{"issue":"5","key":"79_CR92","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/ebm.2011.010360","volume":"236","author":"WX Ding","year":"2011","unstructured":"Ding WX, Manley S, Ni HM. The emerging role of autophagy in alcoholic liver disease. Exp Biol Med (Maywood). 2011;236(5):546\u2013556.","journal-title":"Exp Biol Med (Maywood)."},{"key":"79_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.111075","volume":"136","author":"JA Williams","year":"2020","unstructured":"Williams JA, Ding WX. Role of autophagy in alcohol and drug-induced liver injury. Food Chem Toxicol. 2020;136:111075.","journal-title":"Food Chem Toxicol."},{"issue":"6036","key":"79_CR94","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u20131433.","journal-title":"Science."},{"issue":"12","key":"79_CR95","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/acer.12904","volume":"39","author":"PG Thomes","year":"2015","unstructured":"Thomes PG, Trambly CS, Fox HS, et al. Acute and Chronic Ethanol Administration Differentially Modulate Hepatic Autophagy and Transcription Factor EB. Alcohol Clin Exp Res. 2015;39(12):2354\u20132363.","journal-title":"Alcohol Clin Exp Res."},{"issue":"3","key":"79_CR96","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2018.05.027","volume":"155","author":"X Chao","year":"2018","unstructured":"Chao X, Wang S, Zhao K, et al. Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in\u00a0Mice. Gastroenterology. 2018;155(3):865\u2013879.e12.","journal-title":"Gastroenterology."},{"issue":"4","key":"79_CR97","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12265-010-9200-z","volume":"3","author":"A Ferdous","year":"2010","unstructured":"Ferdous A, Battiprolu PK, Ni YG, et al. FoxO, autophagy, and cardiac remodeling. J Cardiovasc Transl Res. 2010;3(4):355\u2013364.","journal-title":"J Cardiovasc Transl Res."},{"issue":"6","key":"79_CR98","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.ajpath.2013.08.011","volume":"183","author":"HM Ni","year":"2013","unstructured":"Ni HM, Du K, You M, et al. Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity. Am J Pathol. 2013;183(6):1815\u20131825.","journal-title":"Am J Pathol."},{"issue":"6","key":"79_CR99","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u20131669.","journal-title":"Gastroenterology."},{"issue":"Pt 3","key":"79_CR100","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/bj20020949","volume":"368","author":"A Chen","year":"2002","unstructured":"Chen A. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochem J. 2002;368(Pt 3):683\u2013693.","journal-title":"Biochem J."},{"issue":"2","key":"79_CR101","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.20798","volume":"42","author":"G Svegliati-Baroni","year":"2005","unstructured":"Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR, et al. Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology. 2005;42(2):343\u2013352.","journal-title":"Hepatology."},{"issue":"3","key":"79_CR102","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cbi.2011.07.001","volume":"193","author":"E Mormone","year":"2011","unstructured":"Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193(3):225\u2013231.","journal-title":"Chem Biol Interact."},{"issue":"8","key":"79_CR103","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/cvr\/cvz079","volume":"115","author":"J Heger","year":"2019","unstructured":"Heger J, Euler G. The many facets of transcriptional regulation by hypoxia-inducible factor-1. Cardiovasc Res. 2019;115(8):1257\u20131259.","journal-title":"Cardiovasc Res."},{"issue":"6","key":"79_CR104","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcmgh.2015.09.005","volume":"1","author":"KJ Roth","year":"2015","unstructured":"Roth KJ, Copple BL. Role of Hypoxia-Inducible Factors in the Development of\u00a0Liver\u00a0Fibrosis. Cell Mol Gastroenterol Hepatol. 2015;1(6):589\u2013597.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"3","key":"79_CR105","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexmp.2004.08.002","volume":"77","author":"J Li","year":"2004","unstructured":"Li J, French B, Wu Y, et al. Liver hypoxia and lack of recovery after reperfusion at high blood alcohol levels in the intragastric feeding model of alcohol liver disease. Exp Mol Pathol. 2004;77(3):184\u2013192.","journal-title":"Exp Mol Pathol."},{"key":"79_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/712893","volume":"2014","author":"E Raskopf","year":"2014","unstructured":"Raskopf E, Gonzalez Carmona MA, Van Cayzeele CJ, et al. Toxic damage increases angiogenesis and metastasis in fibrotic livers via PECAM-1. Biomed Res Int. 2014;2014:712893.","journal-title":"Biomed Res Int."},{"key":"79_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107791","volume":"222","author":"X Han","year":"2021","unstructured":"Han X, Wu Y, Yang Q, et al. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther. 2021;222:107791.","journal-title":"Pharmacol Ther."},{"key":"79_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-5926-6-7","volume":"6","author":"OA Gressner","year":"2007","unstructured":"Gressner OA, Weiskirchen R, Gressner AM. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol. 2007;6:7.","journal-title":"Comp Hepatol."},{"key":"79_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109176","volume":"327","author":"FG Meng","year":"2020","unstructured":"Meng FG, Zhang XN, Liu SX, et al. Roles of peroxisome proliferator-activated receptor \u03b1 in the pathogenesis of ethanol-induced liver disease. Chem Biol Interact. 2020;327:109176.","journal-title":"Chem Biol Interact."},{"issue":"11","key":"79_CR110","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.3390\/ijms22115717","volume":"22","author":"J Hyun","year":"2021","unstructured":"Hyun J, Han J, Lee C, et al. Pathophysiological Aspects of Alcohol Metabolism in the Liver. Int J Mol Sci. 2021;22(11):5717.","journal-title":"Int J Mol Sci."},{"key":"79_CR111","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/754067","volume":"2012","author":"T Li","year":"2012","unstructured":"Li T, Chiang JYL. Bile Acid signaling in liver metabolism and diseases. J Lipids. 2012;2012:754067.","journal-title":"J Lipids."},{"issue":"2","key":"79_CR112","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","volume":"9","author":"T Li","year":"2020","unstructured":"Li T, Chiang JYL. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr. 2020;9(2):152\u2013169.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"2","key":"79_CR113","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.apsb.2014.12.011","volume":"5","author":"S Manley","year":"2015","unstructured":"Manley S, Ding W. Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B. 2015;5(2):158\u2013167.","journal-title":"Acta Pharm Sin B."},{"issue":"4","key":"79_CR114","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.dld.2018.12.026","volume":"51","author":"B Kong","year":"2019","unstructured":"Kong B, Zhang M, Huang M, et al. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. Dig Liver Dis. 2019;51(4):570\u2013576.","journal-title":"Dig Liver Dis."},{"issue":"3","key":"79_CR115","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","volume":"56","author":"B Kong","year":"2012","unstructured":"Kong B, Wang L, Chiang JYL, et al. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 2012;56(3):1034\u20131043.","journal-title":"Hepatology."},{"issue":"1","key":"79_CR116","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","volume":"443","author":"W Wu","year":"2014","unstructured":"Wu W, Zhu B, Peng X, et al. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Biochem Biophys Res Commun. 2014;443(1):68\u201373.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"79_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000771","volume":"65","author":"H Wade","year":"2021","unstructured":"Wade H, Pan K, Su Q. CREBH: A Complex Array of Regulatory Mechanisms in Nutritional Signaling, Metabolic Inflammation, and Metabolic Disease. Mol Nutr Food Res. 2021;65(1):e2000771.","journal-title":"Mol Nutr Food Res."},{"issue":"7","key":"79_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068845","volume":"8","author":"D Chanda","year":"2013","unstructured":"Chanda D, Kim YH, Li T, et al. Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH. PLoS One. 2013;8(7):e68845.","journal-title":"PLoS One."},{"issue":"43","key":"79_CR119","doi-asserted-by":"publisher","first-page":"41163","DOI":"10.1074\/jbc.M202653200","volume":"277","author":"B Courselaud","year":"2002","unstructured":"Courselaud B, Pigeon C, Inoue Y, et al. C\/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C\/EBP pathway and iron metabolism. J Biol Chem. 2002;277(43):41163\u201341170.","journal-title":"J Biol Chem."},{"issue":"1","key":"79_CR120","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1530-0277.2006.00002.x","volume":"30","author":"K Bridle","year":"2006","unstructured":"Bridle K, Cheung TK, Murphy T, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res. 2006;30(1):106\u2013112.","journal-title":"Alcohol Clin Exp Res."},{"key":"79_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12950-016-0135-2","volume":"13","author":"J Naidenow","year":"2016","unstructured":"Naidenow J, Hrgovic I, Doll M, et al. Peroxisome proliferator-activated receptor (PPAR) \u03b1 and \u03b4 activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. J Inflamm (Lond). 2016;13:27.","journal-title":"J Inflamm (Lond)."},{"issue":"4","key":"79_CR122","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/jm8014124","volume":"52","author":"B Flatt","year":"2009","unstructured":"Flatt B, Martin R, Wang TL, et al. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J Med Chem. 2009;52(4):904\u2013907.","journal-title":"J Med Chem."},{"issue":"4","key":"79_CR123","doi-asserted-by":"publisher","first-page":"G833","DOI":"10.1152\/ajpgi.90358.2008","volume":"295","author":"JM Ajmo","year":"2008","unstructured":"Ajmo JM, Liang X, Rogers CQ, et al. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol. 2008;295(4):G833\u2013G842.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"19","key":"79_CR124","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365(19):1781\u20131789.","journal-title":"N Engl J Med."},{"issue":"4","key":"79_CR125","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","volume":"44","author":"M Phillips","year":"2006","unstructured":"Phillips M, Curtis H, Portmann B, et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol. 2006;44(4):784\u2013790.","journal-title":"J Hepatol."},{"issue":"2","key":"79_CR126","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","volume":"47","author":"S Stewart","year":"2007","unstructured":"Stewart S, Prince M, Bassendine M, et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47(2):277\u2013283.","journal-title":"J Hepatol."},{"issue":"4","key":"79_CR127","doi-asserted-by":"publisher","first-page":"99312","DOI":"10.3748\/wjg.v31.i4.99312","volume":"31","author":"L Pirola","year":"2025","unstructured":"Pirola L. Elafibranor, a dual PPAR\u03b1 and PPAR\u03b4 agonist, reduces alcohol-associated liver disease: Lessons from a mouse model. World J Gastroenterol. 2025;31(4):99312.","journal-title":"World J Gastroenterol."},{"issue":"12 Suppl","key":"79_CR128","first-page":"240S","volume":"29","author":"K Tomita","year":"2005","unstructured":"Tomita K, Tamiya G, Ando S, et al. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res. 2005;29(12 Suppl):240S\u2013245S.","journal-title":"Alcohol Clin Exp Res."},{"issue":"11","key":"79_CR129","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1080\/15548627.2022.2046457","volume":"18","author":"DJ Samuvel","year":"2022","unstructured":"Samuvel DJ, Li L, Krishnasamy Y, et al. Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice. Autophagy. 2022;18(11):2671\u20132685.","journal-title":"Autophagy."},{"key":"79_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.apha.2019.01.008","volume":"85","author":"X Chao","year":"2019","unstructured":"Chao X, Ding WX. Role and mechanisms of autophagy in alcohol-induced liver injury. Adv Pharmacol. 2019;85:109\u2013131.","journal-title":"Adv Pharmacol."},{"key":"79_CR131","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.taap.2018.08.019","volume":"357","author":"J Sun","year":"2018","unstructured":"Sun J, Fu J, Li L, et al. Nrf2 in alcoholic liver disease. Toxicol Appl Pharmacol. 2018;357:62\u201369.","journal-title":"Toxicol Appl Pharmacol."},{"issue":"36","key":"79_CR132","doi-asserted-by":"publisher","first-page":"12908","DOI":"10.3748\/wjg.v20.i36.12908","volume":"20","author":"JA Williams","year":"2014","unstructured":"Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol. 2014;20(36):12908\u201312933.","journal-title":"World J Gastroenterol."},{"issue":"5","key":"79_CR133","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jhep.2019.01.021","volume":"70","author":"C Sanz-Garcia","year":"2019","unstructured":"Sanz-Garcia C, Poulsen KL, Bellos D, et al. The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice. J Hepatol. 2019;70(5):974\u2013984.","journal-title":"J Hepatol."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00079-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:28Z","timestamp":1758772948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00079-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Paticipate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}